Quality not quantity for transglutaminase antibody 2: The performance of an endomysial and tissue transglutaminase test in screening coeliac disease remains stable over time

Clinical and Experimental Immunology

Volumn 171, Issue 1, 2013, Pages 100-106

  Swallow, K ^a   Wild, G ^a   Sargur, R ^a   Sanders, D S ^b   Aziz, I ^b   Hopper, A D ^b   Egner, W ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Biopsy; Coeliac disease; Endomysial antibodies (EMA); Guidelines; Tissue transglutaminase (TG2)

Indexed keywords

ENDOMYSIUM ANTIBODY; IMMUNOGLOBULIN A; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2 ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY TITER; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SEROLOGY;

AUTOANTIBODIES; CELIAC DISEASE; CLINICAL AUDIT; DIAGNOSTIC ERRORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GTP-BINDING PROTEINS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTESTINAL MUCOSA; MASS SCREENING; MUSCLE FIBERS, SKELETAL; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; TRANSGLUTAMINASES;

EID: 84870417100     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12000     Document Type: Article

References (26)

1. National Institute of Clinical Excellence (NICE) guideline 86. Coeliac disease: recognition and assessment of coeliac disease. Manchester, UK: NICE, 2009.
2. Husby S, Koletzko S, Korponay-Szabo IR etal. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012; 54:136-160.
3. Hopper AD, Hadjivassiliou M, Hurlstone DP etal. What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis. Clin Gastroenterol Hepatol 2008; 6:314-320.
4. West J, Lloyd CA, Hill PG etal. IgA-antitissue transglutaminase: validation of a commercial assay for diagnosing coeliac disease. Clin Lab 2002; 48:241-246.
5. Hopper AD, Cross SS, Hurlstone DP etal. Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool. BMJ 2007; 334:729-734.
6. Evans KE, Sanders DS. What is the use of biopsy and antibodies in coeliac disease diagnosis? J Intern Med 2011; 269:572-581.
7. Walker MM, Talley NJ. Clinical value of duodenal biopsies-beyond the diagnosis of coeliac disease. Pathol Res Pract 2011; 207:538-544.
8. Aziz I, Evans KE, Hopper AD etal. A prospective study into the aetiology of lymphocytic duodenosis. Aliment Pharm Ther 2010; 32:1392-1397.
9. Walker MM, Murray JA, Ronkainen J etal. Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology 2010; 139:112-119.
10. Egner W, Shrimpton A, Sargur R etal. ESPGHAN guidance on coeliac disease 2012: multiples of the upper limit of normal for decision making do not harmonise assay performance across centres. J Pediatr Gastroenterol Nutr 2012. doi: 10.1097/MPG.0b013e31826531f6.
11. Green PH, Jabri B. Coeliac disease. Lancet 2003; 362:383-391.
12. Lo Iacono O, Petta S, Venezia G etal. Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always coeliac disease? Am J Gastroenterol 2005; 100:2472-2477.
13. Reeves GE, Squance ML, Duggan AE etal. Diagnostic accuracy of coeliac serological tests: a prospective study. Eur J Gastroenterol Hepatol 2006; 18:493-501.
14. Sweis R, Pee L, Smith-Laing G. Discrepancies between histology and serology for the diagnosis of coeliac disease in a district general hospital: is this an unrecognised problem in other hospitals? Clin Med 2009; 9:346-348.
15. Hopper AD, Hadjivassiliou M, Butt S etal. Adult coeliac disease. BMJ 2007; 335:558-562.
16. Feighery L, Collins C, Feighery C etal. Anti-transglutaminase antibodies and the serological diagnosis of coeliac disease. Br J Biomed Sci 2003; 60:14-18.
17. Evans KE, Malloy AR, Gorard DA. Changing patterns of coeliac serology requests. Aliment Pharmacol Ther 2009; 29:1137-1142.
18. Johnston SD, McMillan SA, Collins JS etal. A comparison of antibodies to tissue transglutaminase with conventional serological tests in the diagnosis of coeliac disease. Eur J Gastroenterol Hepatol 2003; 15:1001-1004.
19. Agreus L, Svardsudd K, Tibblin G etal. Endomysium antibodies are superior to gliadin antibodies in screening for coeliac disease in patients presenting supposed functional gastrointestinal symptoms. Scand J Prim Health Care 2000; 18:105-110.
20. Lock RJ, Stevens S, Pitcher MC etal. Is immunoglobulin A anti-tissue transglutaminase antibody a reliable serological marker of coeliac disease? Eur J Gastroenterol Hepatol 2004; 16:467-470.
21. Hill PG, Holmes GK. Coeliac disease: a biopsy is not always necessary for diagnosis. Aliment Pharmacol Ther 2008; 27:572-577.
22. Hill PG, Forsyth JM, Semeraro D etal. IgA antibodies to human tissue transglutaminase: audit of routine practice confirms high diagnostic accuracy. Scand J Gastroenterol 2004; 39:1078-1082.
23. Wong RC, Steele RH, Reeves GE etal. Antibody and genetic testing in coeliac disease. Pathology 2003; 35:285-304.
24. Van Meensel B, Hiele M, Hoffman I etal. Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac disease. Clin Chem 2004; 50:2125-2135.
25. Duncan AH, Peter G. A review of the quality of gastrointestinal investigations performed in UK laboratories. Ann Clin Biochem 2007; 44 (Pt 2):145-158.
26. Li M, Yu L, Tiberti C etal. A report on the International Transglutaminase Autoantibody Workshop for Coeliac Disease. Am J Gastroenterol 2009; 104:154-163.